Gritstone Bio Inc (GRTS)
0.7826
+0.04
(+4.82%)
USD |
NASDAQ |
May 17, 16:00
0.7826
0.00 (0.00%)
After-Hours: 20:00
Gritstone Bio SG&A Expense (Quarterly): 8.502M for March 31, 2024
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 8.502M |
December 31, 2023 | 7.916M |
September 30, 2023 | 7.406M |
June 30, 2023 | 6.716M |
March 31, 2023 | 6.745M |
December 31, 2022 | 6.761M |
September 30, 2022 | 6.462M |
June 30, 2022 | 7.792M |
March 31, 2022 | 7.955M |
December 31, 2021 | 6.682M |
September 30, 2021 | 6.373M |
June 30, 2021 | 5.937M |
March 31, 2021 | 6.941M |
December 31, 2020 | 5.66M |
Date | Value |
---|---|
September 30, 2020 | 5.031M |
June 30, 2020 | 5.255M |
March 31, 2020 | 5.465M |
December 31, 2019 | 5.615M |
September 30, 2019 | 4.582M |
June 30, 2019 | 4.835M |
March 31, 2019 | 4.377M |
December 31, 2018 | 3.866M |
September 30, 2018 | 3.088M |
June 30, 2018 | 2.814M |
March 31, 2018 | 2.038M |
December 31, 2017 | 1.828M |
September 30, 2017 | 1.404M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
4.582M
Minimum
Sep 2019
8.502M
Maximum
Mar 2024
6.432M
Average
6.572M
Median
SG&A Expense (Quarterly) Benchmarks
Precision BioSciences Inc | 8.428M |
Humacyte Inc | 5.314M |
Verastem Inc | 10.35M |
BioVie Inc | 2.254M |
Adial Pharmaceuticals Inc | 1.519M |